f182112

Dose-Escalation Study, Relapsed or Refractory Multiple Myeloma

Shandong New Time Pharmaceutical Co., LTDPhase 3

—

Rating in progress

f182112 in Dose-Escalation Study, Relapsed or Refractory Multiple Myeloma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active